| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| I811964 | MACKLIN | 伊维茵素 | 97% | 125元/1g; 494元/5g; 1366元/25g; 3600元/100g; | 咨询 |
|
| I854556 | MACKLIN | 伊维茵素 | 98% | 160元/1g; 557元/5g; 1698元/25g; 3991元/100g; | 咨询 |
|
| I0819 | TCI | Ivermectin | >93.0%(HPLC) | 180元/1G; 660元/5G; | 咨询 |
基本信息 | 纯度/分析方法 | >93.0%(HPLC) | | 分子式/分子量 | C48H74O14 = 875.11 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 应避免的情况 | 加热 | | Reaxys-RN | 8400552 | | Merck Index (14) | 5248 | | MDL编号 | MFCD00869511 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 93.0 area% |
物性(参考值) | 熔点 | 155 ℃ | | 水溶性 | 实际上不溶 | | 溶解性(可溶于) | 甲醇,乙醇,二乙醚 |
安全信息 | 图形或危害标志 |    | | 信号词 | 危险 | | 危险性说明 | H300 : 吞咽致命。 H361 : 怀疑对生育能力或胎儿造成伤害。 H362 : 可能对母乳喂养的儿童造成伤害。 H410 : 对水生生物毒性极大并具有长期持续影响。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P263 : 怀孕/ 哺乳期间避免接触。 P273 : 避免释放到环境中。 P260 : 不要吸入粉尘或烟雾。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P391 : 收集溢出物。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | I | | 监管条件代码(*) | |
|
| 511423 | J&K | Ivermectin | 96% | 725元/100MG; | 咨询 |
基本信息 | 分子式 | C48H74O14 | | 分子量 | 875.11 | | MDL编码 | MFCD00869511 | | Merck | 14,5248 | | EINECS 编号 | 274-536-0 | | 存储条件 | Store at 2-8℃ |
安全信息 | 图形或危害标志 |   | | 提示语 | Danger | | 危险说明 | H300 H351 H360D | | 防范说明 | P201 P264 P281 P301+P310 P308+P313 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | II | | WGK | 3 | | RTECS | IH7891500 |
|
| PHR1380 | Supelco | Ivermectin | Pharmaceutical Secondary Standard; Certified Reference Material | 1471.28元/1 G; | 咨询 |
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。 依维菌素是阿维菌素B1的衍生物,用于杀灭兽医应用中的内部和外部寄生物。它还被用作控制旋盘尾丝虫的潜在药物,这种寄生虫经鉴定是人类′河盲症′的病因。 应用 依维菌素可用作药物参考标准品,用于通过色谱技术测定药物制剂和血浆样品中的分析物。 这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。 分析说明 这些二级标准品可追溯至USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 要查看该材料的分析证书示例,请在下面的栏位中输入 LRAA1636。这只是一个示例证书,可能不是您收到的批次。 基本信息 | EC 号 | 274-536-0 | | MDL编号 | MFCD00869511 | | PubChem化学物质编号 | 329823357 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 864 traceable to PhEur I8000010 traceable to USP 1354309 | | 储存温度 | 2-8℃ | | SMILES string | [H][C@@]1(O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2)[C@@H](C)CC | | InChI | 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 | | InChI key | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H300 - H311 - H410 | | 预防措施声明 | P264 - P270 - P273 - P280 - P301 + P310 - P302 + P352 + P312 | | 危险分类 | Acute Tox. 1 Oral - Acute Tox. 3 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| I8000010 | | Ivermectin | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | MDL编号 | MFCD00869511 | | PubChem化学物质编号 | 329815318 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | [H][C@@]1(O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2)[C@@H](C)CC | | InChI | 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 | | InChI key | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H300 - H311 - H410 | | 预防措施声明 | P264 - P270 - P273 - P280 - P301 + P310 - P302 + P352 + P312 | | 危险分类 | Acute Tox. 1 Oral - Acute Tox. 3 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP864 | | Ivermectin | British Pharmacopoeia (BP) Reference Standard | 290.15元/250 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 250 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | EC 号 | 274-536-0 | | MDL编号 | MFCD00869511 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 质量 | British Pharmacopoeia (BP) Reference Standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [H][C@@]1(O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2)[C@@H](C)CC | | InChI | 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 | | InChI key | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H300 - H311 - H410 | | 预防措施声明 | P264 - P270 - P273 - P280 - P301 + P310 - P302 + P352 + P312 | | 危险分类 | Acute Tox. 1 Oral - Acute Tox. 3 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1354309 | USP | Ivermectin | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | MDL编号 | MFCD00869511 | | PubChem化学物质编号 | 329750214 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [H][C@@]1(O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2)[C@@H](C)CC | | InChI | 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 | | InChI key | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H300 - H311 - H410 | | 预防措施声明 | P264 - P270 - P273 - P280 - P301 + P310 - P302 + P352 + P312 | | 危险分类 | Acute Tox. 1 Oral - Acute Tox. 3 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| P-1084S-CN | AccuStandard | Ivermectin,100 μg/mL in Acetonitrile | 100 μg/mL in Acetonitrile | 185元/1mL; | 咨询 |
| Ivermectin | 伊维菌素 | 70288-86-7 | 100 µg/mL |
|
| P-1084S-CN-10X | AccuStandard | Ivermectin,1000 μg/mL in Acetonitrile | 1000 μg/mL in Acetonitrile | 386元/1mL; | 咨询 |
| Ivermectin | 伊维菌素 | 70288-86-7 | 100 µg/mL |
|